Review: D-Galactosamine lethality model: scope and limitations
- 1 June 2004
- journal article
- review article
- Published by SAGE Publications in Innate Immunity
- Vol. 10 (3) , 147-162
- https://doi.org/10.1177/09680519040100030201
Abstract
D-Galactosamine (D-galN) is well established as sensitizing mice and other animals to the lethal effects of TNF, specifically, and by several orders of magnitude. Protection by anti-TNF neutralizing antibody is complete, as is (metabolically-based) protection by uridine. Sensitization occurs regardless of the origin of the released TNF, whether it is released from macrophages and/or T-cells. The same is true for the challenging agent which leads to the release of TNF, whether it is endotoxin, a superantigen, lipoprotein, bacterial DNA, or bacteria, either killed or proliferating. Most studies have utilized endotoxin as the challenging agent, and more than 70 agents have been reported to confer protection against LPS and/or TNF challenge in the model. The model has provided new insight regarding modes of protection, including from dexamethasone, which protects against challenge from LPS but not from challenge by TNF. The D-galN lethality model has also been used to test for synergistic behavior between different bacterial components, and to test for lethality when only small amounts of the challenging agent are available (lipid A chemistry).Keywords
This publication has 195 references indexed in Scilit:
- PEPTIDOGLYCAN PRIMES FOR LPS-INDUCED RELEASE OF PROINFLAMMATORY CYTOKINES IN WHOLE HUMAN BLOODShock, 2001
- Biological Properties of Lipid A Isolated fromFlavobacterium meningosepticumClinical and Diagnostic Laboratory Immunology, 2001
- Adenovirus-Mediated Hepatocyte Growth Factor Gene Transfer Prevents Lethal Liver Failure in RatsBiochemical and Biophysical Research Communications, 2000
- Deferoxamine reduces tissue injury and lethality in LPS-treated miceInternational Journal of Immunopharmacology, 2000
- Bacterial DNA as an evolutionary conserved ligand signalling danger of infection to immune cellsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Biological activities and antitumor effects of synthetic lipid a analog linked n-acylated serineInternational Journal of Immunopharmacology, 1995
- MODULATION OF THE RELEASE OF CYTOKINES AND REDUCTION OF THE SHOCK SYNDROME INDUCED BY ANTI-CD3 MONOCLONAL ANTIBODY IN MICE BY INTERLEUKIN-10Transplantation, 1994
- Inhibition of Endotoxin-Induced Macrophage Tumor Necrosis Factor Expression by a Prostacyclin Analogue and Its Beneficial Effect in Experimental Lipopolysaccharide IntoxicationThe Journal of Infectious Diseases, 1992
- Glucocorticoid‐dependent and ‐independent mechanisms involved in lipopolysaccharide toleranceEuropean Journal of Immunology, 1991
- Biological activities of chemically synthesized N‐acetylneuraminic acid‐(α2→6) ‐monosaccharide analogs of lipid AFEBS Letters, 1988